Access cutting-edge breast cancer treatment through this clinical trial at a research site in Fairhope. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Fairhope at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop t
Sponsor: Alliance for Clinical Trials in Oncology
Check if you qualify for this breast cancer clinical trial in Fairhope, AL
If you're searching for breast cancer treatment options in Fairhope, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fairhope research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.